e2027
Small moleculeexperimental
Clinical trial activity
6 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2015 (NCT02415790)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- e2027
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04764669 | Phase 2 | Feb 25, 2021 | Eisai |
| NCT04023877 | Phase 1 | Jul 17, 2019 | Eisai |
| NCT03467152 | Phase 2 | May 4, 2018 | Eisai |
| NCT02947711 | Phase 1 | Oct 1, 2016 | Eisai |
| NCT02873156 | Phase 1 | Aug 1, 2016 | Eisai |
| NCT02415790 | Phase 1 | Jul 1, 2015 | Eisai |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Eisai | For profit | 6 | 6 | 2 | 2015 |
1 organizations
Page 1 / 1